In-bound supply chain strategic framework

Broadcast date

Fri, Sep 10, 2021

 

Presented by

    Guido Kremer - Global BioPharm Center of Excellence at Merck
    Benjamin Jequier - Takeda

 

Quick Description

If we are to adjust to the new normal as we move from ‘Covid-19 pandemic to endemic’, industry must take ownership of the in-bound supply chain.

Details

If we are to adjust to the new normal as we move from ‘Covid-19 pandemic to endemic’, industry must take ownership of the in-bound supply chain. It needs an overarching strategy to guide plans for solving the most critical issues and strengthen and advance in-bound supply chain operations.

BioPhorum’s Supply Partner leadership team decided it needed to ‘own’ this action and has launched its Strategic Framework for the Development of the Biopharmaceutical Manufacturing Industry In-Bound Supply Chain. The Framework is patient-centric, responds to regulatory affairs, and will allow the industry to focus on solving the industry’s most important challenges.

In this webinar, Guido Kremer, Senior Consultant, Global BioPharm Center of Excellence at Merck, and Benjamin Jequier, Head of Site Supply Chain at Takeda discuss the importance of creating this framework and the value that it will bring.

Speakers

Guido Kremer

Senior Consultant

Global BioPharm Center of Excellence at Merck

Benjamin Jequier

Head of Site Supply Chain

Takeda